Report Cover

Global Leishmaniasis Treatment Market Research Report 2022


Leishmaniasis Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Leishmaniasis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
    Meglumine Antimoniate
    Pentamidine
    Hydroxyl Amidine Stilbene
    Amphotericin B
Segment by Application
    Visceral Leishmaniasis
    Cutaneous Leishmaniasis
By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    Asia-Pacific
        China
        Japan
        South Korea
        Southeast Asia
        India
        Australia
        Rest of Asia
    Latin America
        Mexico
        Brazil
        Rest of Latin America
    Middle East & Africa
        Turkey
        Saudi Arabia
        UAE
        Rest of MEA
By Company
    Merck
    iCo Therapeutics
    AEterna Zentaris
    AEterna Zentaris AG
    Eurofins Advinus
    Pieris Pharmaceuticals
    Dafra Pharma
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Leishmaniasis Treatment Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Meglumine Antimoniate
        1.2.3 Pentamidine
        1.2.4 Hydroxyl Amidine Stilbene
        1.2.5 Amphotericin B
    1.3 Market by Application
        1.3.1 Global Leishmaniasis Treatment Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Visceral Leishmaniasis
        1.3.3 Cutaneous Leishmaniasis
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Leishmaniasis Treatment Market Perspective (2017-2028)
    2.2 Leishmaniasis Treatment Growth Trends by Region
        2.2.1 Leishmaniasis Treatment Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Leishmaniasis Treatment Historic Market Size by Region (2017-2022)
        2.2.3 Leishmaniasis Treatment Forecasted Market Size by Region (2023-2028)
    2.3 Leishmaniasis Treatment Market Dynamics
        2.3.1 Leishmaniasis Treatment Industry Trends
        2.3.2 Leishmaniasis Treatment Market Drivers
        2.3.3 Leishmaniasis Treatment Market Challenges
        2.3.4 Leishmaniasis Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Leishmaniasis Treatment Players by Revenue
        3.1.1 Global Top Leishmaniasis Treatment Players by Revenue (2017-2022)
        3.1.2 Global Leishmaniasis Treatment Revenue Market Share by Players (2017-2022)
    3.2 Global Leishmaniasis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Leishmaniasis Treatment Revenue
    3.4 Global Leishmaniasis Treatment Market Concentration Ratio
        3.4.1 Global Leishmaniasis Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Leishmaniasis Treatment Revenue in 2021
    3.5 Leishmaniasis Treatment Key Players Head office and Area Served
    3.6 Key Players Leishmaniasis Treatment Product Solution and Service
    3.7 Date of Enter into Leishmaniasis Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Leishmaniasis Treatment Breakdown Data by Type
    4.1 Global Leishmaniasis Treatment Historic Market Size by Type (2017-2022)
    4.2 Global Leishmaniasis Treatment Forecasted Market Size by Type (2023-2028)
5 Leishmaniasis Treatment Breakdown Data by Application
    5.1 Global Leishmaniasis Treatment Historic Market Size by Application (2017-2022)
    5.2 Global Leishmaniasis Treatment Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Leishmaniasis Treatment Market Size (2017-2028)
    6.2 North America Leishmaniasis Treatment Market Size by Country (2017-2022)
    6.3 North America Leishmaniasis Treatment Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Leishmaniasis Treatment Market Size (2017-2028)
    7.2 Europe Leishmaniasis Treatment Market Size by Country (2017-2022)
    7.3 Europe Leishmaniasis Treatment Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Leishmaniasis Treatment Market Size (2017-2028)
    8.2 Asia-Pacific Leishmaniasis Treatment Market Size by Country (2017-2022)
    8.3 Asia-Pacific Leishmaniasis Treatment Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Leishmaniasis Treatment Market Size (2017-2028)
    9.2 Latin America Leishmaniasis Treatment Market Size by Country (2017-2022)
    9.3 Latin America Leishmaniasis Treatment Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Leishmaniasis Treatment Market Size (2017-2028)
    10.2 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2017-2022)
    10.3 Middle East & Africa Leishmaniasis Treatment Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Merck
        11.1.1 Merck Company Detail
        11.1.2 Merck Business Overview
        11.1.3 Merck Leishmaniasis Treatment Introduction
        11.1.4 Merck Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.1.5 Merck Recent Development
    11.2 iCo Therapeutics
        11.2.1 iCo Therapeutics Company Detail
        11.2.2 iCo Therapeutics Business Overview
        11.2.3 iCo Therapeutics Leishmaniasis Treatment Introduction
        11.2.4 iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.2.5 iCo Therapeutics Recent Development
    11.3 AEterna Zentaris
        11.3.1 AEterna Zentaris Company Detail
        11.3.2 AEterna Zentaris Business Overview
        11.3.3 AEterna Zentaris Leishmaniasis Treatment Introduction
        11.3.4 AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.3.5 AEterna Zentaris Recent Development
    11.4 AEterna Zentaris AG
        11.4.1 AEterna Zentaris AG Company Detail
        11.4.2 AEterna Zentaris AG Business Overview
        11.4.3 AEterna Zentaris AG Leishmaniasis Treatment Introduction
        11.4.4 AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.4.5 AEterna Zentaris AG Recent Development
    11.5 Eurofins Advinus
        11.5.1 Eurofins Advinus Company Detail
        11.5.2 Eurofins Advinus Business Overview
        11.5.3 Eurofins Advinus Leishmaniasis Treatment Introduction
        11.5.4 Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.5.5 Eurofins Advinus Recent Development
    11.6 Pieris Pharmaceuticals
        11.6.1 Pieris Pharmaceuticals Company Detail
        11.6.2 Pieris Pharmaceuticals Business Overview
        11.6.3 Pieris Pharmaceuticals Leishmaniasis Treatment Introduction
        11.6.4 Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.6.5 Pieris Pharmaceuticals Recent Development
    11.7 Dafra Pharma
        11.7.1 Dafra Pharma Company Detail
        11.7.2 Dafra Pharma Business Overview
        11.7.3 Dafra Pharma Leishmaniasis Treatment Introduction
        11.7.4 Dafra Pharma Revenue in Leishmaniasis Treatment Business (2017-2022)
        11.7.5 Dafra Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables Table 1. Global Leishmaniasis Treatment Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028 Table 2. Key Players of Meglumine Antimoniate Table 3. Key Players of Pentamidine Table 4. Key Players of Hydroxyl Amidine Stilbene Table 5. Key Players of Amphotericin B Table 6. Global Leishmaniasis Treatment Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Leishmaniasis Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 8. Global Leishmaniasis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 9. Global Leishmaniasis Treatment Market Share by Region (2017-2022) Table 10. Global Leishmaniasis Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 11. Global Leishmaniasis Treatment Market Share by Region (2023-2028) Table 12. Leishmaniasis Treatment Market Trends Table 13. Leishmaniasis Treatment Market Drivers Table 14. Leishmaniasis Treatment Market Challenges Table 15. Leishmaniasis Treatment Market Restraints Table 16. Global Leishmaniasis Treatment Revenue by Players (2017-2022) & (US$ Million) Table 17. Global Leishmaniasis Treatment Market Share by Players (2017-2022) Table 18. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2021) Table 19. Ranking of Global Top Leishmaniasis Treatment Companies by Revenue (US$ Million) in 2021 Table 20. Global 5 Largest Players Market Share by Leishmaniasis Treatment Revenue (CR5 and HHI) & (2017-2022) Table 21. Key Players Headquarters and Area Served Table 22. Key Players Leishmaniasis Treatment Product Solution and Service Table 23. Date of Enter into Leishmaniasis Treatment Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global Leishmaniasis Treatment Market Size by Type (2017-2022) & (US$ Million) Table 26. Global Leishmaniasis Treatment Revenue Market Share by Type (2017-2022) Table 27. Global Leishmaniasis Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 28. Global Leishmaniasis Treatment Revenue Market Share by Type (2023-2028) Table 29. Global Leishmaniasis Treatment Market Size by Application (2017-2022) & (US$ Million) Table 30. Global Leishmaniasis Treatment Revenue Market Share by Application (2017-2022) Table 31. Global Leishmaniasis Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 32. Global Leishmaniasis Treatment Revenue Market Share by Application (2023-2028) Table 33. North America Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 34. North America Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 35. Europe Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 36. Europe Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 37. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2017-2022) & (US$ Million) Table 38. Asia-Pacific Leishmaniasis Treatment Market Size by Region (2023-2028) & (US$ Million) Table 39. Latin America Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 40. Latin America Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 41. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2017-2022) & (US$ Million) Table 42. Middle East & Africa Leishmaniasis Treatment Market Size by Country (2023-2028) & (US$ Million) Table 43. Merck Company Detail Table 44. Merck Business Overview Table 45. Merck Leishmaniasis Treatment Product Table 46. Merck Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 47. Merck Recent Development Table 48. iCo Therapeutics Company Detail Table 49. iCo Therapeutics Business Overview Table 50. iCo Therapeutics Leishmaniasis Treatment Product Table 51. iCo Therapeutics Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 52. iCo Therapeutics Recent Development Table 53. AEterna Zentaris Company Detail Table 54. AEterna Zentaris Business Overview Table 55. AEterna Zentaris Leishmaniasis Treatment Product Table 56. AEterna Zentaris Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 57. AEterna Zentaris Recent Development Table 58. AEterna Zentaris AG Company Detail Table 59. AEterna Zentaris AG Business Overview Table 60. AEterna Zentaris AG Leishmaniasis Treatment Product Table 61. AEterna Zentaris AG Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 62. AEterna Zentaris AG Recent Development Table 63. Eurofins Advinus Company Detail Table 64. Eurofins Advinus Business Overview Table 65. Eurofins Advinus Leishmaniasis Treatment Product Table 66. Eurofins Advinus Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 67. Eurofins Advinus Recent Development Table 68. Pieris Pharmaceuticals Company Detail Table 69. Pieris Pharmaceuticals Business Overview Table 70. Pieris Pharmaceuticals Leishmaniasis Treatment Product Table 71. Pieris Pharmaceuticals Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 72. Pieris Pharmaceuticals Recent Development Table 73. Dafra Pharma Company Detail Table 74. Dafra Pharma Business Overview Table 75. Dafra Pharma Leishmaniasis Treatment Product Table 76. Dafra Pharma Revenue in Leishmaniasis Treatment Business (2017-2022) & (US$ Million) Table 77. Dafra Pharma Recent Development Table 78. Research Programs/Design for This Report Table 79. Key Data Information from Secondary Sources Table 80. Key Data Information from Primary Sources List of Figures Figure 1. Global Leishmaniasis Treatment Market Share by Type: 2021 VS 2028 Figure 2. Meglumine Antimoniate Features Figure 3. Pentamidine Features Figure 4. Hydroxyl Amidine Stilbene Features Figure 5. Amphotericin B Features Figure 6. Global Leishmaniasis Treatment Market Share by Application in 2021 & 2028 Figure 7. Visceral Leishmaniasis Case Studies Figure 8. Cutaneous Leishmaniasis Case Studies Figure 9. Leishmaniasis Treatment Report Years Considered Figure 10. Global Leishmaniasis Treatment Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 11. Global Leishmaniasis Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 12. Global Leishmaniasis Treatment Market Share by Region: 2021 VS 2028 Figure 13. Global Leishmaniasis Treatment Market Share by Players in 2021 Figure 14. Global Top Leishmaniasis Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Leishmaniasis Treatment as of 2021) Figure 15. The Top 10 and 5 Players Market Share by Leishmaniasis Treatment Revenue in 2021 Figure 16. North America Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 17. North America Leishmaniasis Treatment Market Share by Country (2017-2028) Figure 18. United States Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 19. Canada Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 20. Europe Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 21. Europe Leishmaniasis Treatment Market Share by Country (2017-2028) Figure 22. Germany Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. France Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 24. U.K. Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 25. Italy Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 26. Russia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 27. Nordic Countries Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. Asia-Pacific Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. Asia-Pacific Leishmaniasis Treatment Market Share by Region (2017-2028) Figure 30. China Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Japan Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. South Korea Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Southeast Asia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 34. India Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 35. Australia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 36. Latin America Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 37. Latin America Leishmaniasis Treatment Market Share by Country (2017-2028) Figure 38. Mexico Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. Brazil Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Middle East & Africa Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. Middle East & Africa Leishmaniasis Treatment Market Share by Country (2017-2028) Figure 42. Turkey Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 43. Saudi Arabia Leishmaniasis Treatment Market Size YoY Growth (2017-2028) & (US$ Million) Figure 44. Merck Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 45. iCo Therapeutics Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 46. AEterna Zentaris Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 47. AEterna Zentaris AG Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 48. Eurofins Advinus Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 49. Pieris Pharmaceuticals Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 50. Dafra Pharma Revenue Growth Rate in Leishmaniasis Treatment Business (2017-2022) Figure 51. Bottom-up and Top-down Approaches for This Report Figure 52. Data Triangulation Figure 53. Key Executives Interviewed

This research study involved the extensive usage of both primary and secondary data sources.  The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. Top-down and bottom-up approaches are used to validate the global market size market and estimate the market size for manufacturers, regions segments, product segments and applications (end users). All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or other factors are not accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from QYResearch and presented in this report.
 

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation, extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub segments listed in this report. Extensive qualitative and further quantitative analysis is also done from all the numbers arrived at in the complete market engineering process to list key information throughout the report.
 

Secondary Sources occupies Approximately 25% of Sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on; This research study involved the usage of widespread secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; BIS Statistics; ICIS; company house documents; CAS(American Chemical Society); investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the Light Aircraft market. It was also used to obtain important information about the top players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.
 

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers etc.
 

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
 

Primary research was conducted to identify segmentation types, product price range, product applications, key players, raw materials supply and the downstream demand, industry status and outlook, and key market dynamics such as risks, influence factors, opportunities, market barriers, industry trends, and key player strategies.
 

Publisher: QY Research
Chat with us